Human Genome Epidemiology Literature Finder
|
Records 1 - 11 (of 11 Records) |
| Query Trace: Autoimmune Diseases and FCGR3A[original query] |
|---|
| Association of FcgR2a, but not FcgR3a, with inflammatory bowel diseases across three Caucasian populations. Inflammatory bowel diseases 2010 Dec 16 (12): 2080-9. Weersma Rinse K, Crusius J Bart A, Roberts Rebecca L, Koeleman Bobby P C, Palomino-Morales Rogelio, Wolfkamp Simone, Hollis-Moffatt Jade E, Festen Eleonora A M, Meisneris Sander, Heijmans Roel, Noble Colin L, Gearry Richard B, Barclay Murrary L, Gómez-Garcia María, Lopez-Nevot Miguel A, Nieto Antonio, Rodrigo Luis, Radstake Timothy R D J, van Bodegraven Adriaan A, Wijmenga Cisca, Merriman Tony R, Stokkers Pieter C F, Peña A Salvador, Martín Javier, Alizadeh Behrooz |
| Copy number, linkage disequilibrium and disease association in the FCGR locus. Human molecular genetics 2010 Aug 19 (16): 3282-94. Niederer Heather A, Willcocks Lisa C, Rayner Tim F, Yang Wanling, Lau Yu Lung, Williams Thomas N, Scott J Anthony G, Urban Britta C, Peshu Norbert, Dunstan Sarah J, Hien Tran Tinh, Phu Nguyen Hoan, Padyukov Leonid, Gunnarsson Iva, Svenungsson Elisabet, Savage Caroline O, Watts Richard A, Lyons Paul A, Clayton David G, Smith Kenneth G |
| Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia. British journal of haematology 2012 Jul . Cooper N, Stasi R, Cunningham-Rundles S, Cesarman E, McFarland JG, Bussel JB |
| Association of the FCGR3A-158F/V gene polymorphism with the response to rituximab treatment in Spanish systemic autoimmune disease patients. DNA and cell biology 2012 Oct . Robledo G, Márquez A, Dávila-Fajardo CL, Ortego-Centeno N, Rubio JL, Garrido ED, Sánchez-Román J, García-Hernández FJ, Ríos-Fernández R, González-Escribano MF, García MT, Palma MJ, Ayala MD, Martín J |
| Impact of allele copy number of polymorphisms in FCGR3A and FCGR3B genes on susceptibility to ulcerative colitis. Inflammatory bowel diseases 2013 Sep 19 (10): 2061-8. Asano Kouichi, Matsumoto Takayuki, Umeno Junji, Hirano Atsushi, Esaki Motohiro, Hosono Naoya, Matsui Toshiyuki, Kiyohara Yutaka, Nakamura Yusuke, Kubo Michiaki, Kitazono Takana |
| HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy. Clinical journal of the American Society of Nephrology : CJASN 2013 Nov . Bullich G, Ballarín J, Oliver A, Ayasreh N, Silva I, Santín S, Díaz-Encarnación MM, Torra R, Ars E |
| A comparison of assays for accurate copy number measurement of the low-affinity Fc gamma receptor genes FCGR3A and FCGR3B. PloS one 2015 10 (1): e0116791. Haridan Umi Shakina, Mokhtar Umairah, Machado Lee R, Abdul Aziz Abu Thalhah, Shueb Rafidah Hanim, Zaid Masliza, Sim Benedict, Mustafa Mahiran, Nik Yusof Nik Khairudin, Lee Christopher K C, Abu Bakar Suhaili, AbuBakar Sazaly, Hollox Edward J, Boon Peng H |
| Impact of Fc?R variants on the response to alemtuzumab in multiple sclerosis. Annals of clinical and translational neurology 2019 Nov . Keller Christian W, Ruck Tobias, McHugh Donal, Pfeuffer Steffen, Gross Catharina C, Korsukewitz Catharina, Melzer Nico, Klotz Luisa, Meuth Sven G, Münz Christian, Nimmerjahn Falk, Wiendl Heinz, Lünemann Jan |
| Exploring pharmacogenetic variants for predicting response to anti-TNF therapy in autoimmune diseases: a meta-analysis. Pharmacogenomics 2021 4 22 (7): 435-445. Antonatos Charalabos, Stavrou Eleana F, Evangelou Evangelos, Vasilopoulos Yiann |
| Association between functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to rituximab in patients with autoimmune diseases: a meta-analysis. The pharmacogenomics journal 2023 5 . Young Ho Lee, Gwan Gyu So |
| Frequency of pharmacogenomic variants affecting safety and efficacy of immunomodulators and biologics in a South Asian population from Sri Lanka. Human genomics 2024 9 18 (1): 107. Priyanga Ranasinghe, Chiranthi Liyanage, Nirmala Sirisena, Sandamini Liyanage, C D Nelanka Priyadarshani, D P Bhagya Hendalage, Vajira H W Dissanaya |
- Page last reviewed:Feb 1, 2024
- Content source: